Last reviewed · How we verify
Prurigo nodularis
Approved treatments
- Dupixent · Regeneron
Dupixent blocks the interleukin-4 receptor, a key player in the immune system's inflammatory response.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Prurigo nodularis patent landscape — cliff calendar, originator estates, attackable patents
- Prurigo nodularis treatment landscape brief
- Prurigo nodularis treatment updates RSS
Frequently asked questions about Prurigo nodularis
What drugs treat Prurigo nodularis?
Tracked treatments include Dupixent.
What is the treatment for Prurigo nodularis?
Standard treatment for Prurigo nodularis includes Dupixent. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Prurigo nodularis patent cliff · Prurigo nodularis CI report
- Treatment: Dupixent · Regeneron
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing